Kaplan + Sadock's Synopsis of Psychiatry, 11e - page 13

xii Contents
20.10 Tobacco-Related Disorders 680
20.11 Anabolic-Androgenic Steroid Abuse 685
20.12 Other Substance Use and Addictive
Disorders 689
20.13 Gambling Disorder 690
21 Neurocognitive Disorders 694
21.1 Introduction and Overview 694
21.2 Delirium 697
21.3 Dementia (Major Neurocognitive
Disorder) 704
21.4 Major or Minor Neurocognitive
Disorder Due to Another Medical
Condition (Amnestic Disorders) 718
21.5 Neurocognitive and Other Disorders
Due to a General Medical Condition 723
21.6 Mild Cognitive Impairment 737
22 Personality Disorders 742
23 Emergency Psychiatric Medicine 763
23.1 Suicide 763
23.2 Psychiatric Emergencies in Adults 774
23.3 Psychiatric Emergencies in Children 785
24 Complementary and Alternative
Medicine in Psychiatry 791
25 Other Conditions that May be a
Focus of Clinical Attention 812
26 Physical and Sexual Abuse of Adults 824
27 Psychiatry and Reproductive
Medicine 831
28 Psychotherapies 845
28.1 Psychoanalysis and Psychoanalytic
Psychotherapy 845
28.2 Brief Psychodynamic Psychotherapy 853
28.3 Group Psychotherapy,
Combined Individual and Group
Psychotherapy, and Psychodrama 857
28.4 Family Therapy and Couples Therapy 863
28.5 Dialectical Behavior Therapy 868
28.6 Biofeedback 869
28.7 Cognitive Therapy 873
28.8 Behavior Therapy 877
28.9 Hypnosis 883
28.10 Interpersonal Therapy 887
28.11 Narrative Psychotherapy 891
28.12 Psychiatric Rehabilitation 894
28.13 Combined Psychotherapy and
Pharmacology 897
28.14 Genetic Counseling 901
28.15 Mentalization-Based Therapy and
Mindfulness 907
29 Psychopharmacological Treatment 910
29.1 General Principles of
Psychopharmacology 910
29.2 Medication-Induced Movement
Disorders 923
29.3 a2 -Adrenergic Receptor Agonists,
a1 -Adrenergic Receptor Antagonists:
Clonidine, Guanfacine, Prazosin, and
Yohimbine 929
29.4 b-Adrenergic Receptor
Antagonists 933
29.5 Anticholinergic Agents 936
29.6 Anticonvulsants 938
29.7 Antihistamines 942
29.8 Barbiturates and Similarly Acting
Drugs 944
29.9 Benzodiazepines and Drugs
Acting on GABA Receptors 948
29.10 Bupropion 954
29.11 Buspirone 956
29.12 Calcium Channel Blockers 957
29.13 Carbamazepine and Oxcarbazepine 959
29.14 Cholinesterase Inhibitors and
Memantine 963
29.15 Disulfiram and Acamprosate 966
29.16 Dopamine Receptor Agonists and
Precursors 969